• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Changes in dyspnea, health status, and lung function in chronic airway disease.

作者信息

Mahler D A, Tomlinson D, Olmstead E M, Tosteson A N, O'Connor G T

机构信息

Department of Medicine, Dartmouth Medical School, Lebanon, New Hampshire 03756-0001.

出版信息

Am J Respir Crit Care Med. 1995 Jan;151(1):61-5. doi: 10.1164/ajrccm.151.1.7812573.

DOI:10.1164/ajrccm.151.1.7812573
PMID:7812573
Abstract

The purpose of this study was to examine longitudinal changes in clinical parameters in patients with chronic obstructive pulmonary disease (COPD). We postulated that progressive dyspnea and decline in lung function over time would influence or impact patient's health status. Clinical ratings of dyspnea, general health status, and physiologic lung function were measured every 6 mo over a 2-yr period in an original group of 110 male patients with stable but symptomatic COPD and no significant comorbidity. At enrollment, age was 67 +/- 8 yr (mean +/- SD), forced expiratory volume in one second (FEV1) was 1.28 +/- 0.59 I (44 +/- 17% of predicted), and forced vital capacity (FVC) was 2.84 +/- 0.84 I (68 +/- 18% of predicted). A total of 34 patients "dropped out" because of death (n = 20), relocation (n = 7), and other reasons (n = 7). Dyspnea was measured using the transition dyspnea index (TDI), which represented changes from the baseline state; general health status was measured using the Medical Outcomes Study (MOS) 20-item short-form survey; physiologic lung function was assessed by spirometry (FVC and FEV1) and inspiratory muscle strength (PImax). Statistical analyses were performed using all available data for each patient, including results until the time at which patients died or were lost to follow-up.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
Changes in dyspnea, health status, and lung function in chronic airway disease.
Am J Respir Crit Care Med. 1995 Jan;151(1):61-5. doi: 10.1164/ajrccm.151.1.7812573.
2
Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease.呼吸困难和生理功能对慢性阻塞性肺疾病患者总体健康状况的影响。
Chest. 1992 Aug;102(2):395-401. doi: 10.1378/chest.102.2.395.
3
A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者呼吸困难评分、呼吸肌力量和肺功能的因素分析。
Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):467-70. doi: 10.1164/ajrccm/145.2_Pt_1.467.
4
Health status, dyspnea, lung function and exercise capacity in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的健康状况、呼吸困难、肺功能及运动能力
Int J Tuberc Lung Dis. 1999 Oct;3(10):920-6.
5
Longitudinal changes in patient-reported dyspnea in patients with COPD.COPD 患者报告的呼吸困难的纵向变化。
COPD. 2012 Aug;9(5):522-7. doi: 10.3109/15412555.2012.701678. Epub 2012 Aug 9.
6
Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease.用于测量慢性阻塞性肺疾病患者健康相关生活质量的疾病特异性问卷之间的鉴别特性比较。
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):785-90. doi: 10.1164/ajrccm.157.3.9703055.
7
Comparison of functional state between bilateral lung volume reduction surgery and pulmonary rehabilitation: a six-month followup study.
Int J Surg Investig. 1999;1(2):139-47.
8
Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者运动期间症状、肺过度充气及耐力的测量
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1557-65. doi: 10.1164/ajrccm.158.5.9804004.
9
Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.吸入性支气管扩张剂可减轻慢性阻塞性肺疾病患者运动期间的动态肺过度充气。
Am J Respir Crit Care Med. 1996 Mar;153(3):967-75. doi: 10.1164/ajrccm.153.3.8630581.
10
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.系统性硬化症合并活动性肺泡炎患者呼吸困难程度与健康相关生活质量、功能能力及一氧化碳弥散能力的相关性:硬皮病肺部研究结果
Arthritis Rheum. 2005 Feb;52(2):592-600. doi: 10.1002/art.20787.

引用本文的文献

1
Dynamic changes in quality of life in older patients with chronic obstructive pulmonary disease: a 7-year follow up.慢性阻塞性肺疾病老年患者生活质量的动态变化:7 年随访研究。
Health Qual Life Outcomes. 2024 Sep 11;22(1):76. doi: 10.1186/s12955-024-02296-1.
2
Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial.吸气肌训练促进 COVID-19 后康复:一项随机对照试验。
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.03101-2021. Print 2022 Oct.
3
Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease.
运用高分辨率 CT 的阶段性变化来监测环磷酰胺或霉酚酸酯对系统性硬化症相关间质性肺病的影响。
Arthritis Rheumatol. 2020 Feb;72(2):316-325. doi: 10.1002/art.41085. Epub 2019 Dec 26.
4
Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts.探讨年龄对慢性阻塞性肺疾病健康结局的影响:来自慢性阻塞性肺疾病遗传流行病学研究和评估慢性阻塞性肺疾病纵向以确定预测替代终点队列的结果。
J Am Med Dir Assoc. 2017 Dec 1;18(12):1063-1068. doi: 10.1016/j.jamda.2017.09.028.
5
Greater dyspnea is associated with lower health-related quality of life among European patients with COPD.在欧洲慢性阻塞性肺疾病(COPD)患者中,更严重的呼吸困难与更低的健康相关生活质量相关。
Int J Chron Obstruct Pulmon Dis. 2017 Mar 20;12:937-944. doi: 10.2147/COPD.S123744. eCollection 2017.
6
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.降钙素原指导慢性阻塞性肺疾病严重加重期的抗生素治疗:一项随机非劣效性试验
PLoS One. 2015 Mar 11;10(3):e0118241. doi: 10.1371/journal.pone.0118241. eCollection 2015.
7
Pain in patients with COPD: a systematic review and meta-analysis.慢性阻塞性肺疾病患者的疼痛:一项系统评价与荟萃分析
BMJ Open. 2014 Sep 26;4(9):e005898. doi: 10.1136/bmjopen-2014-005898.
8
Association between COPD Assessment Test (CAT) and Disease Severity Based on Reduction of Respiratory Volumes in Chemical Warfare Victims.
Tanaffos. 2011;10(4):38-42.
9
Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.慢性阻塞性肺疾病中吸入性糖皮质激素:支持与反对的观点
Br J Clin Pharmacol. 2014 Aug;78(2):282-300. doi: 10.1111/bcp.12334.
10
ACCORD COPD II: a randomized clinical trial to evaluate the 12-week efficacy and safety of twice-daily aclidinium bromide in chronic obstructive pulmonary disease patients.ACCORD慢性阻塞性肺疾病研究II:一项评估每日两次使用阿地溴铵治疗慢性阻塞性肺疾病患者12周疗效和安全性的随机临床试验。
Clin Drug Investig. 2013 Dec;33(12):893-904. doi: 10.1007/s40261-013-0138-1.